Literature DB >> 24522193

CIIA negatively regulates the Ras-Erk1/2 signaling pathway through inhibiting the Ras-specific GEF activity of SOS1.

Hyun Sub Hwang1, Sang Gil Hwang, Kyoung-Wan Yoon, Je-Hyun Yoon, Kyung-Hye Roh, Eui-Ju Choi.   

Abstract

Son of sevenless 1 (SOS1) is a Ras-specific guanine-nucleotide-exchange factor (GEF) that mediates intracellular signaling processes induced by receptor tyrosine kinases. In this study, we show that CIIA (also known as VPS28) physically associates with SOS1 and thereby inhibits the GEF activity of SOS1 on Ras, which prevents the epidermal growth factor (EGF)-induced activation of the Ras-Erk1/2 pathway. Furthermore, CIIA inhibited cyclin D1 expression, as well as DNA, synthesis in response to EGF. Intriguingly, CIIA failed to inhibit the Ras-specific GEF activity of Noonan-syndrome-associated SOS1 mutants (M269R, R552G, W729L and E846K). Taken together, our results suggest that CIIA functions as a negative modulator of the SOS1-Ras signaling events initiated by peptide growth factors including EGF.

Entities:  

Keywords:  CIIA; Ras; SOS1; VPS28

Mesh:

Substances:

Year:  2014        PMID: 24522193     DOI: 10.1242/jcs.139931

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  3 in total

1.  RC3/neurogranin negatively regulates extracellular signal-regulated kinase pathway through its interaction with Ras.

Authors:  Kanghyun Ryoo; Sang-Gil Hwang; Kwang Je Kim; Eui-Ju Choi
Journal:  Mol Cell Biochem       Date:  2014-12-30       Impact factor: 3.396

Review 2.  Intersectin-1s deficiency in pulmonary pathogenesis.

Authors:  Niranjan Jeganathan; Dan Predescu; Sanda Predescu
Journal:  Respir Res       Date:  2017-09-06

3.  In-Silico and In-Vitro Analysis of Human SOS1 Protein Causing Noonan Syndrome - A Novel Approach to Explore the Molecular Pathways.

Authors:  Vinoth Sigamani; Sheeja Rajasingh; Narasimman Gurusamy; Arunima Panda; Johnson Rajasingh
Journal:  Curr Genomics       Date:  2021-12-31       Impact factor: 2.689

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.